Presentation and Management of Paroxysmal Nocturnal Hemoglobinuria: A Single-Center Experience.

about

Presentation and Management of Paroxysmal Nocturnal Hemoglobinuria: A Single-Center Experience.

Item

http://www.wikidata.org/entity/Q36751227

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Presentation and Management of ...... a: A Single-Center Experience.

@en

type

Item

label

Presentation and Management of ...... a: A Single-Center Experience.

@en

prefLabel

Presentation and Management of ...... a: A Single-Center Experience.

@en

P1476

Presentation and Management of ...... a: A Single-Center Experience.

@en

P2093

Abdullah Karakuş

http://www.w3.org/2001/XMLSchema#string

Mehmet Sinan Dal

http://www.w3.org/2001/XMLSchema#string

Mehmet Önder Ekmen

http://www.w3.org/2001/XMLSchema#string

Orhan Ayyildiz

http://www.w3.org/2001/XMLSchema#string

P2860

Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria

Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria.

Baseline characteristics and disease burden in patients in the International Paroxysmal Nocturnal Hemoglobinuria Registry.

Paroxysmal nocturnal hemoglobinuria clones in severe aplastic anemia patients treated with horse anti-thymocyte globulin plus cyclosporine.

Sustained response and long-term safety of eculizumab in paroxysmal nocturnal hemoglobinuria.

The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria.

Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria: the AEGIS clinical trial.

Long-term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria.

Treatment of severe aplastic anemia with a combination of horse antithymocyte globulin and cyclosporine, with or without sirolimus: a prospective randomized study

Eculizumab: a review of its use in paroxysmal nocturnal haemoglobinuria.

P304

6409

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4081/HR.2016.6409

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

299553650

http://www.w3.org/2001/XMLSchema#string

P698

27103981

http://www.w3.org/2001/XMLSchema#string

P932

4815950

http://www.w3.org/2001/XMLSchema#string